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Background: Urinary tract infections (UTIs) are among the most common infections in
the pediatric population. Over the last two decades, antibiotic resistance is increasing
significantly as extended spectrum beta lactamase (ESBL) producing organisms are
emerging. The aim of this study is to provide a comprehensive view of the epidemiologic
characteristics of UTIs in hospitalized children, examine the risk factors of UTIs caused
by ESBL-producing organisms, and determine the resistance patterns in the isolated
organisms over the last 10 years.
Methods: Retrospective chart review was conducted at two Lebanese medical centers.
Subjects were identified by looking at the following ICD-9 discharge codes: “Urinary
tract infection,” “UTI,” “Cystitis,” and/or “Pyelonephritis.” Children less than 18 years
of age admitted for UTI between January 1st, 2001 and December 31st, 2011 were
included. Cases whose urine culture result did not meet our definition for UTI were
excluded. Chi-square, Fisher’s exact test, and multivariate logistic regression were used
to determine risk factors for ESBL. Linear regression analysis was used to determine
resistance patterns.
Results: The study included 675 cases with a median age of 16 months and female
predominance of 77.7% (525 cases). Of the 584 cases caused by Escherichia coli
or Klebsiella spp, 91 cases (15.5%) were found to be ESBL-producing organisms.
Vesico-ureteral reflux and previous antibiotics use were found to be independent risk
factors for ESBL-producing E. coli and Klebsiella spp. (p < 0.05). A significant
linear increase in resistance to all generations of Cephalosporins (r2= 0.442) and
Fluoroquinolones (r2 = 0.698) was found.
Conclusion: The recognition of risk factors for infection with ESBL-producing organisms
and the observation of increasing overall resistance to antibiotics warrant further studies
that might probably lead to new recommendations to guide management of UTIs and
antibiotic use in children and adolescents.
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Introduction
Urinary tract infections (UTIs) are among the most commonly
encountered infections in the pediatric age group both in the
community and hospital settings (Ronald et al., 2001; Stamm
and Norrby, 2001; Nicolle, 2002; Hooton et al., 2004). Several
studies from the United States of America estimate the direct
and indirect cost of acute pyelonephritis in adults to 2.14 billion
US dollars (year 2000 values) which is 2.19 billion US dollars
in 2013 (Brown et al., 2005; Foxman, 2014). It is estimated that
150 million UTIs occur yearly worldwide, resulting in more than
6 billion dollars in direct healthcare cost (Stamm and Norrby,
2001).
Over the last two decades, the resistance to antibiotics
in members of Gram-negative Enterobacteriaceae rose
tremendously worldwide; highlighted by the emergence of
extended spectrum beta-lactamase (ESBL) producing organisms
(Ena et al., 2006; Pitout and Laupland, 2008; Ben-Ami et al.,
2009; Soraas et al., 2013). Whereas the initial spread was
in hospital settings, eventually these pathogens emerged in
community-onset UTIs (Pitout and Laupland, 2008). In many
countries of the Middle East, where unregulated prescription
of antibiotics is prevalent, the resistance patterns of frequently
observed uropathogens are alarming (Kanafani et al., 2005;
Topaloglu et al., 2010; Daoud and Afif, 2011; Araj et al., 2012;
Kizilca et al., 2012; Pourakbari et al., 2012; Al-Assil et al., 2013;
Dayan et al., 2013; Dotis et al., 2013; Megged, 2014). However,
there is limited data concerning the antibiotic resistance pattern
of pediatric UTIs in the region of the Middle East.
Few studies have investigated the prevalence and risk
factors associated with hospital and community-acquired UTIs
secondary to ESBL-producing bacteria in the pediatric age group.
Previous studies have shown that renal abnormalities,
septicemia, systemic disease such as metabolic diseases and
malignancies, hospitalization within the previous 3 months
preceding the onset of UTI, age less than 1 year, high recurrence
rate of UTI, and recent antibiotic treatment are independent
risk factors for UTI secondary to community-acquired ESBL-
producing organisms (Topaloglu et al., 2010; Kizilca et al., 2012;
Dayan et al., 2013; Dotis et al., 2013; Giardino et al., 2013;
Megged, 2014). Those risk factors have not been well established
in our region.
Accordingly, the purpose of this retrospective study is to
provide a comprehensive review of the epidemiology and
characteristics of UTIs in hospitalized children and adolescents,
determine the risk factors of UTIs caused by ESBL-producing
organisms of E. coli andKlebsiella spp, and examine the resistance
patterns in the isolated organisms over the last 10 years.
Materials and Methods
Study Design
A multi-center retrospective cohort study was conducted in two
major Lebanese hospitals both in Beirut; the AmericanUniversity
of Beirut Medical Center (AUBMC) and Makassed General
Hospital (MGH). The study was approved by the institutional
review board (IRB) at each center (the AUB IRB approval number
was PED.RW.01, the MGH IRB approval number was dated 12
June 2013).
All patients were identified retrospectively through medical
records at AUBMC and MGH by looking at the following ICD-
9 codes for discharge diagnosis: “Urinary tract infection,” “UTI,”
“Cystitis,” and/or “Pyelonephritis.” Children less than 18 years
of age with one of the above discharge diagnosis, admitted to
the hospital between January 1st, 2001 and December 31st, 2011
were included in the study. We excluded patients whose urine
culture result did not meet the definition for UTI established
according to the clinical practice guidelines issued in 2011 for the
diagnosis and management of UTI (Roberts, 2011). Accordingly,
this included significant bacteriuria with recovery of at least
100,000 CFU/mL (colony forming unit per milliliter) of a single
uropathogen from a clean catch specimen; or at least 50,000 CFU/
mL of a single uropathogen from a catheterized specimen; or any
uropathogenic bacteria from a suprapubic aspirate.
Data Collection
Data from each reviewed chart was documented on a case
report form (CRF). Data collected included the following
information: basic demographics (age, gender), hospital stay
information (ICU/regular floor admission, length of stay),
past medical history (underlying diseases, genitourinary
disorders, immunosuppression), previous antibiotic use, recent
hospitalizations, past surgical history, method of urine collection,
laboratory information (urinalysis, urine culture, antimicrobial
susceptibility patterns, complete blood count, basic metabolic
panel), imaging results, clinical course and outcomes.
Analysis and Reporting of Results
The Statistical Package for Social Sciences (SPSS) program,
version 22.0 for Windows was used for data analysis (IBM,
Armonk, NY). Simple descriptive statistics were used to describe
patients’ demographics and characteristics of UTI. Bivariate and
multivariate analyses of risk factors for ESBL were first analyzed
by Pearson’s Chi-square test or Fisher’s exact test (when number
of subjects in a subgroup was less than 5). Continuous risk factors
were analyzed with student t-test. Statistical significance was
considered below a type-1 error threshold (alpha level) of 0.05.
Following that amultivariate logistic regressionmodel comprised
of significant risk factors was constructed and reported.
Linear regression analysis was conducted to determine
resistance patterns to different classes of antibiotics over the past
10 years (correlation coefficient r2 and p-value for regression
analysis were reported).
Results
Number of Cases
Cases were identified and included in our study as shown in
Figure 1. Our search retrieved 1650 cases: 719 at AUBMC and
931 at MGH. Only 666 records at AUBMC and 915 records at
MGH were available for review. Of these, 211 cases at AUBMC
and 394 cases at MGH were excluded for either having missing
urine culture data or a negative urine culture result (no growth).
The remaining cases were reviewed. Of these, 182 cases at
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FIGURE 1 | Identification and inclusion of cases into the study.
AUBMC and 119 cases at MGH did not meet our definition of
UTI and were excluded from the study. Therefore, a total of 675
cases were included in the analysis.
Demographic Characteristics
Our study population was divided into three groups, (less than 2
months, between 2 months and 2 years, and more than 2 years),
which had a distribution of 9.5, 49.6, and 40.9% respectively.
Overall, females were predominant (77.7%). However, in infants
less than 2 months, 60.9% were males (Table 1). The median age
was 16 months. The majority of males were circumcised (66%).
Isolated Microorganisms
E. coli was the most common pathogen isolated among all age
groups, followed by Klebsiella and Proteus species, accounting
for 79.4, 7.9 and 3.9% respectively. Other organisms such as
Pseudomonas, Enterococcus, and Enterobacter were relatively rare
(Table 2).
Imaging and Laboratory Findings
Renal ultrasound was performed in 69.8% of cases, 24.8% of the
results were abnormal. Dilation of the pelvicalyceal system was
TABLE 1 | Gender distribution by age groups.
Gender Age group n (%) Total
<2 months 2 months–2 years >2 years
Females 25 (39.1) 254 (75.8) 246 (89.1) 525 (77.7)
Males 39 (60.9) 81 (24.2) 30 (10.9) 150 (22.3)
Total 64 (9.5) 335 (49.6) 276 (40.9) 675
TABLE 2 | Isolated uropathogens by age groups.
Organisms Total n (%) Age groups n (%)
<2 months 2 months >2 years
–2 years
E. coli 536 (79.4) 39 (60.9) 266 (79.4) 231 (83.7)
Klebsiella spp. 53 (7.8) 18 (28.1) 26 (7.7) 9 (3.3)
Proteus spp. 26 (3.8) 1 (1.6) 12 (3.6) 13 (4.7)
Pseudomonas
aeruginosa
14 (2.1) 1 (1.6) 5 (1.5) 8 (2.9)
Enterococcus spp. 14 (2.1) 0 (0) 8 (2.4) 6 (2.2)
Enterobacter spp. 10 (1.5) 2 (3.1) 6 (1.8) 2 (0.7)
Others* 22 (3.3) 3 (4.7) 12 (3.6) 7 (2.5)
Total 675 (100) 64 (100) 335 (100) 276 (100)
*Others: Candida albicans, Candida non-albicans, coagulase negative Staphylococcus,
Group B Streptococcus, Providencia startii, Citrobacter freundii, viridans group
streptococci, Serratia marcescens, Morganella morgani, Alcaligenes faecalis, Citrobacter
diversus, Salmonella group C.
the most common finding, representing 41.9% of abnormalities.
Voiding cystourethrogram (VCUG) was performed in 53.4% of
the cases with an abnormal ultrasound. Vesicoureteral reflux
(VUR) was identified in 51% of these cases. In addition, 49.3%
of the cases with normal ultrasound findings underwent VCUG,
of which 19% had VUR (Figure 2).
Out of 273 cases from AUBMC, 103 underwent
Dimercaptosuccinic acid (DMSA) radio-nucleotide scans,
of which 60 cases had scarring or foci of pyelonephritis. No
DMSA data was reported from MGH, as this procedure was
not available in this hospital. When comparing ESBL and
non-ESBL-producing E. coli and Klebsiella spp, 25.5% of cases
with abnormal DMSA results had ESBL positive UTI.
Urinalysis showed a high white blood cell (WBC) count of
more than 5 per high-power field (HPF) in only 60.1% of cases.
Leukocyte esterase and nitrites were positive in only 80.2 and 39%
of our cases, respectively. Approximately one third of patients
(34.9%) had all three positive findings present on urinalysis.
ESBL Risk Factors and Emergence Patterns
The ESBL-producing and non-ESBL-producing groups consisted
of 91 (15.5%) and 493 (84.5%) cases, respectively. ESBL cases
were significantly more frequent at AUBMC (p < 0.05). For 5
of the 589 cases caused by E. coli or Klebsiella spp, the data on
ESBL status was missing.
Median age, gender, and age group distribution revealed
no significant differences between the ESBL-producing and
non-ESBL-producing groups. In the ESBL-producing group,
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FIGURE 2 | Imaging results for ultrasound and voiding cystourethrogram (VCUG).
E. coli and Klebsiella isolates represented 82.4% and 17.6%,
respectively; whereas, in the non-ESBL-producing group, E. coli
and Klebsiella isolates represented 92.5 and 7.5%, respectively.
Thus, Klebsiella spp. were more commonly found in the ESBL-
producing group (p = 0.02). Additionally, longer duration of
hospital stay was found to be statistically significant in cases with
ESBL-producing organisms (p < 0.001) (Table 3).
Clinical Characteristics
When comparing ESBL and non-ESBL groups, there was no
significant difference in the presenting symptoms regarding fever,
vomiting, diarrhea, irritability, abdominal pain, flank pain and
voiding dysfunction. However, enuresis was significantly higher
in the ESBL group (p < 0.05).
Although liver, renal, and cardiac diseases were more
prevalent in ESBL cases, the difference was not statistically
significant (p > 0.05). On the other hand, VUR, recurrent
UTI, and history of genitourinary (GU) surgery were found to
be significantly higher in ESBL group (p < 0.05). Regarding
circumcision, no significant difference was observed (p = 0.703)
(Table 4).
A multivariate logistic regression analysis was performed with
the above risk factors while controlling for age and gender. VUR
and previous antibiotic use were found to be independent risk
factors with odds ratio (OR) of 3.01 and 4.05, respectively.
Resistance to Different Classes of Antibiotics
When a linear regression was performed comparing ESBL
pattern over the past 10 years, a significant association was found
(p = 0.004) (Figure 3). There was a strong positive linear
correlation (r2 = 0.783), with a 2.08% yearly increase in UTIs
secondary to ESBL-producing bacteria.
To observe the trends in UTI resistance to different classes of
antibiotics in the period of 2001 to 2011, we plotted the yearly
percentage of UTIs resistant to gentamicin, cephalosporins,
TABLE 3 | Characteristics of ESBL and Non-ESBL groups.
ESBL Non-ESBL p-value†
(N = 91) (N = 493)
Median age in months 23 15
Mean age in months 38.8 38 0.883*
Female Gender, n (%) 77 (84.6) 395 (80.2) 0.318
AGE GROUPS, N (%)
<2 months 8 (8.8) 48 (9.7) 0.368
2 months–2 years 40 (44) 251 (51)
>2 years 43 (47.2) 194 (39.3)
PREVALENCE BY LOCATION (%)
MGH 12.1 87.9 0.004
AUBMC 21.1 78.9
ORGANISMS, N (%)
E. coli 75 (82.4) 456 (92.5) 0.020
Klebsiella spp. 16 (17.6) 37 (7.5)
Mean LOS 14.33 6.48 <0.001*
LOS Length of hospital stay in days.
*Independent Sample-t test is used to compare means.
†Pearson’s Chi-Square test was used (no expected count less than 5).
fluoroquinolones, and trimethoprim-sulfamethoxazole (TMP-
SMX). Resistance to first generation cephalosporins could not be
evaluated because it is not tested for by the hospitals’ laboratories
included in this study. Since the trends in antibiotic resistance
to second, third, and fourth generations of cephalosporins were
very similar, we grouped the three generations of cephalosporins
into one class. The fluoroquinolone class of antibiotics in our
study included levofloxacin and ciprofloxacin; resistance to other
fluoroquinolones is not tested by the hospitals’ laboratories
included in this study. The trends in antibiotic resistance to
levofloxacin and ciprofloxacin were also similar.
Linear regression revealed statistically significant linear trends
in antibiotic resistance to fluoroquinolones (p = 0.001) and
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TABLE 4 | Possible risk factors for ESBL cases.
Risk factors ESBL n (%) Non-ESBL n (%) p-value†
Systemic diseases** 4 (4.4) 18 (3.7) 0.763*
Renal disease 8 (8.8) 20 (4.1) 0.062*
PUV 3 (3.3) 1 (0.2) 0.013*
VUR 13 (14.3) 14 (2.8) <0.001*
Recurrent UTI 36 (39.6) 76 (15.4) <0.001
GU surgery 13 (14.3) 15 (3) <0.001*
Circumcision 10 (76.9) 69 (82.1) 0.703*
Urinary catheter 7 (7.7) 13 (2.6) 0.024*
Non-GU surgery 18 (19.8) 48 (9.7) 0.005
Previous antibiotic use 34 (37.4) 46 (9.3) <0.001
Use of suppressive antibiotic 15 (16.5) 12 (2.4) <0.001*
Previous hospitalization 19 (20.9) 26 (5.3) <0.001
Immunocompromised*** 12 (13.2) 22 (4.5) 0.001
Chemotherapy 11 (12.1) 7 (1.4) <0.001*
Radiation therapy 3 (3.3) 3 (0.6) 0.051*
Diarrhea in the preceding week 15 (16.5) 94 (19.1) 0.561
Constipation 6 (6.6) 21 (4.3) 0.411
Toilet training: urine 28 (30.8) 156 (31.6) 0.869
Toilet training: stool 29 (31.9) 157 (31.8) 0.997
CVC or Arterial line 14 (15.4) 20 (4.1) <0.001
ETT 2 (2.2) 4 (0.8) 0.237*
PUV, Posterior urethral valve; CVC, Central venous catheter; ETT, Endotracheal tube.
Significant differences for p-values are indicated in bold.
†Pearson Chi-Square was used (no expected count less than 5).
*Fisher’s exact test was used (at least one expected count less than 5).
**Systemic Diseases: Cardiac disease, liver disease, pulmonary disease and diabetes.
***Primary or secondary to malignancy (lymphoma, leukemia, or solid tumor).
FIGURE 3 | Trend showing percentage of UTIs caused by
ESBL-producing organisms over the 10 year period of the study.
cephalosporins (p = 0.026). No significant linear association was
found for resistance to penicillin derivatives (p = 0.09), amikacin
(p = 0.444), TMP-SMX (p = 0.684), and gentamicin (p = 0.065)
across the years 2001–2011. Significant trends plotted are shown
in Figure 4.
There was a strong linear association for resistance to
fluoroquinolones across time (r2 = 0.698), such that there was
a 1.62% yearly increase in UTIs resistant to fluoroquinolones.
There was a moderate linear association for resistance to
FIGURE 4 | Trend showing percentage of UTIs resistant to
Cephalosporins (N) and Fluoroquinolones () over the 10 year period
of the study.
cephalosporins across time (r2 = 0.442), such that there was a
1.21% yearly increase in UTIs resistant to cephalosporins.
Antibiotic Usage
The most common class of antibiotics used for inpatient
treatment of UTIs in our study was cephalosporins, with 76.9% of
patients with UTIs having used at least one cephalosporin during
inpatient treatment. The most commonly used cephalosporins
were third generation cephalosporins, used in 67.5% of cases.
Second generation cephalosporins were used in 7.1% of cases,
whereas fourth generation cephalosporins were used in 2.5%
of cases. A penicillin derivative, most commonly ampicillin or
amoxicillin-clavulanic acid, were used for inpatient treatment
in 16% of cases. Aminoglycosides (amikacin or gentamicin)
were used in 12.3% of cases. Carbapenems, glycopeptides,
and fluroquinolones were used in 10.5, 3.3, and 1% of cases
respectively. Simultaneous use of two or more antibiotics was
practiced in 10.1% of cases; whereas 22.2% of cases required
sequential use of multiple antibiotics.
Regarding antibiotic use on discharge, 66.2% of cases were
discharged on at least one antibiotic with oral third generation
cephalosporins used in 43.65% of cases.
Discussion
Epidemiologic Characteristics of UTI
UTIs are among the most frequent infections encountered in the
pediatric population. To our knowledge this is the first Lebanese
retrospective pediatric study that reviews the epidemiology of
UTIs in hospitalized children, and outlines the risk factors
and outcomes of UTIs caused by ESBL-producing E. coli and
Klebsiella spp.
The epidemiology of pediatric UTIs depends on several factors
such as age, gender, and genitourinary malformations. Our study
showed an overall female predominance; this could be related to
circumcision as 78% ofmales in our study were circumcised. This
is presumed to be the result of geographic location and religious
affiliation. In addition, the shorter female urethra is a plausible
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explanation of the increased prevalence of UTIs in females. Zorc
et al. mentioned that UTI is prevalent in all children in their first
year but after 1 year of age, it tends to decrease in males due to
multiple factors such as circumcision (Circumcision, 1999).
Approximately, one-fifth of our patients (19.7%) with
normal renal ultrasound had VUR, with approximately one-
fourth (24.1%) being grade V. These findings were similar in
comparison with other studies. Juliano et al. reported that despite
normal renal bladder ultrasound, 24% of their patients had
dilating vesicoureteral reflux (Juliano et al., 2013). Another study
showed that the sensitivity of renal ultrasound in suggesting VUR
was only 40% (Mahant et al., 2002). DiPietro et al found that renal
ultrasound was unreliable in excluding VUR in children aged
5 years or older who were being evaluated for a UTI (Dipietro
et al., 1997). Our study showed that approximately 5% of the
patients who had normal renal ultrasound had VUR grade V
needing surgical management, whichmeans if VCUG is deferred,
according to the last published guidelines in 2011(Roberts, 2011),
parents should be counseled regarding this risk. Thus, if our
findings are confirmed in other similar studies, the guidelines
may have to be revisited.
The absence of pyuria in children with UTIs was found in a
high percentage of cases (40%). This discordance was higher than
that reported in previous studies (27%) (Roberts, 2011). There
was no significant difference in the presence of pyuria between
immunocompromised and non-immunocompromised patients
(64.5% of immunocompromised patients had positive urinalysis
WBC compared to 68% of non-immunocompromised patients).
Nitrites were positive in only 39% of cases of UTI documented
by urine culture. This is lower than the reported sensitivity in
previous studies (53%) (Roberts, 2011). Leucocyte esterase was
positive in 80.2% of cases of UTI documented by urine culture.
This is similar to the reported sensitivity of leucocyte esterase in
various studies (83%) (Roberts, 2011), making it a reliable test for
predicting UTIs in young febrile children.
Risk Factors for ESBL
Our study revealed that E. coli is the most common pathogen
in UTIs among all age groups, whether ESBL or non-ESBL
producers. This finding is compatible with other studies (Calbo
et al., 2006; Topaloglu et al., 2010; Kizilca et al., 2012;
Dotis et al., 2013). Among E. coli and Klebsiella spp, the
proportion of ESBL-producing bacteria was higher in Klebsiella
spp. This was also reported by Kiziliza et al. suggesting that
if the isolated microorganism of UTI belongs to Klebsiella
spp, production of ESBL may be expected more frequently
(Kizilca et al., 2012).
Lautenbach et al. revealed no association between hospital
location and infection with ESBL-producing E. coli or K.
pneumonia (Lautenbach et al., 2001). However, in our study,
we found that ESBL infection is more common at AUBMC
than MGH. This can be attributed to notable differences
between the two hospitals. AUBMC is Lebanon’s largest
medical center, and has referral units for pediatric cardiology,
oncology, neurosurgery and intensive care patients. Although
both hospitals are tertiary care centers, MGH is a smaller
center with fewer facilities than AUBMC. As such, the
cases referred to AUBMC tend to be more complicated
than cases admitted to MGH. As for the association with
immunosuppression: immunosuppression secondary to
malignancy and chemotherapy places the patient at higher risk
of acquiring resistant bacteria (as ESBL producing bacteria) due
to the multiple visits/stays in hospitals and the use of broad
spectrum antibiotics.
Except for enuresis, there were no statistically significant
differences in the presenting symptoms between ESBL and non-
ESBL UTI. This is in contrast to a previous study (Dotis et al.,
2013) that showed children with ESBL UTI presented clinically
with more symptoms than children with non-ESBL UTI. In
fact, our results indicate that UTIs secondary to ESBL-producing
organisms are not associated with a more severe clinical picture.
Some of the risk factors for ESBL UTI that our study
showed to be significant as recurrent UTIs, previous urological
abnormalities, previous antibiotic use, previous hospitalization,
and malignancies were found to be significant in other studies
(Lautenbach et al., 2001; Topaloglu et al., 2010; Kizilca et al., 2012;
Megged, 2014). However, only previous antibiotic use was found
to be an independent risk factor. This is in contrast to the study
by Topaloglu et al. (2010), that found previous antibiotic use was
not an independent risk factor.
The mean length of hospital stay was significantly longer
for patients with UTI caused by ESBL-producing bacteria than
that for patients with UTI caused by non-ESBL-producing
bacteria. This may be attributed to the fact that ESBL treatment
in children necessitates parenteral antibiotic administration
for 7–10 days; as opposed to adults, where oral Ciprofloxacin
is a treatment option for ESBL UTI. Other studies also found
that longer hospitalization periods are needed for the treatment
of ESBL infections (Lautenbach et al., 2001; Megged, 2014).
As quinolones become more routinely used in children and
adolescents, this trend for longer hospitalizations with ESBL
infections may be reversed but the rising quinolone resistance
might cancel this hope.
Resistance Trends and Usage of Different
Classes of Antibiotics
In our study over a 10-year period, there was an alarming
increase in the incidence of ESBL-producing UTIs in hospitalized
children, from 8% in 2001 to 25% in 2011 (Figure 3). A Lebanese
study by Araj et al. on bacterial susceptibility patterns in all
infections among all ages found nearly similar results within the
same time period (Araj et al., 2012). Araj et al. demonstrated an
increase of ESBL-producing E. coli and Klebsiella spp, from 4 and
12% in 2000, to 30 and 28% in 2011, respectively (Araj et al.,
2012). A comparable finding was also demonstrated at another
center in Lebanon by Daoud et al. (Daoud and Afif, 2011),
who observed an increase in UTIs caused by ESBL-producing
organisms from 2.3% in 2000 to 16.8% in 2009 among patients
of all ages. Both studies attributed this finding to uncontrolled
antimicrobial usage in Lebanon (Daoud and Afif, 2011; Araj et al.,
2012).
Although percentage of UTIs resistant to TMP-SMX was
considerably more than resistance to any other antibiotic, there
has been no increase in resistance to TMP-SMX across the
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years. One study in the United States showed that TMP-
SMX is a poor empirical choice in many areas due to high
resistance rates (Edlin et al., 2013). Our study revealed that
in our setting, TMP-SMX still has a role in the treatment of
UTIs; however it is usually reserved for use upon discharge
and is infrequently used as inpatient treatment for hospitalized
patients.
The trend in increasing resistance to fluoroquinolones has
been well established in other studies. A study examining the
epidemiology and resistance in uncomplicated UTI among adult
females in Europe and Brazil found a significant increase in
quinolone resistance of community-acquired urinary E. coli
(Schito et al., 2009). One review attributed this trend in increasing
fluoroquinolone resistance to overuse of this class of antibiotics
(Nickel, 2007). While the results on antibiotic usage within our
cohort reveal relatively controlled usage of fluoroquinolones, one
must keep in mind that our results only shed light on antibiotic
practice in treating UTI in hospitalized children. It is likely that
there is in fact overuse of fluoroquinolones in our population’s
healthcare system, especially among adults in outpatient settings,
leading to community-acquired resistance. In addition, as a
study conducted in Canada has shown (Pepin et al., 2009), risk
factors for the development of UTIs resistant to ciprofloxacin
included the use of aminoglycosides in the last 12 months.
Therefore, the trend of increasing resistance of uropathogens
to fluoroquinolones may also be due to cross-reactivity from
overuse of other antibiotics.
We also observed a significant trend of increasing resistance
to cephalosporins over the study’s 10 year period (Figure 4). This
is likely due to overuse of antibiotics in our community, as our
study has shown that the majority (76.9%) of hospitalized UTIs
were treated with cephalosporins, specifically third generation
cephalosporins. Our dependence on cephalosporins in light of
increasing resistance will pose a challenge in the future, and
emphasizes the need to find alternative antibiotics.
Limitations
Although our study is the first to investigate the epidemiology
of UTIs and risk factors for ESBL in the pediatric population in
Lebanon, it is important to note certain limitations. Our study
only looked at hospitalized children with UTI, and therefore
our findings may not apply to the general pediatric population.
Furthermore, the number of cases included in our study was
restricted by our criteria for defining UTI. A significant number
of cases excluded due to negative or low colony count on urine
culture are likely the result of over-the-counter antibiotic use
before the culture was taken. A study examining the value of
semi-quantitative bacterial counts in establishing the diagnosis
of UTI caused by group B streptococcus in adults demonstrated
occurrence of UTI at values as low as 100 CFU/ml (Tan et al.,
2012). Similarly, in abiding by the cutoffs mentioned in our study
we may have missed a substantial number of UTI cases with
subthreshold colony counts. Finally, our study is not immune to
the inherent limitations of a retrospective chart review; the cases
included in our study were limited by the availability of data and
incomplete medical records, such as missing laboratory results
for urine cultures or other studies that were done in outside
hospitals.
Conclusion
In conclusion, the resistance to commonly used antibiotics for
UTIs has been increasing over the last 10 years, as ESBL-
producing organisms are emerging. The recognition of the
epidemiology and risk factors for ESBL-producing bacteria
in the pediatric population may affect our management and
therapeutic approach. In keeping with our finding that previous
antibiotic use was the most important independent risk factor for
emergence of ESBL-producing bacteria, further studies and new
recommendations that guide management of UTIs and antibiotic
use are warranted.
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